Skip to content

Clinical trials

Completed Endocrine Gland Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine Gland Neoplasms Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20071
20082
20091
20111
20121
20142
20152
20163
20171
20183
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Catalysis SL2
Sumitomo Pharma America, Inc.2
Syndax Pharmaceuticals2
Amgen1
Celgene1
Daniel Bernstein1
Duke University1
Hoffmann-La Roche1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine Gland Neoplasms23
Neoplasms13
Digestive System Neoplasms8
Endocrine System Diseases8
Pancreatic Neoplasms8
Lung Neoplasms7
Neoplasms, Glandular and Epithelial7
Breast Neoplasms6
Digestive System Diseases5
Head and Neck Neoplasms5

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.